TCRTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Alaunos Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$3.13+0.50 (+19.01%)
Close on Oct 19, 2026
- Market cap
- $7.61M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Alaunos Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 13, 2026 | Oct 13, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 5, 2026 | Oct 9, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 18, 2026 | Sep 22, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 16, 2026 | Sep 17, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 14, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 29, 2026 | Jun 29, 2026 | SEC EDGAR |
| Current report | 8-K | May 26, 2026 | May 26, 2026 | SEC EDGAR |
| Current report | 8-K | May 18, 2026 | May 18, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 15, 2026 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2025 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 9, 2026 | Apr 15, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 31, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 2, 2026 | Mar 2, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 8, 2026 | Jan 8, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 17, 2025 | Dec 23, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 14, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 19, 2025 | Aug 20, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 16, 2025 | Jul 22, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 15, 2025 | Jul 17, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 3, 2025 | Jul 10, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 1, 2025 | Jul 2, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 20, 2025 | Jun 26, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 24, 2025 | Jun 26, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 9, 2025 | Jun 10, 2025 | SEC EDGAR |
| Current report | 8-K | May 19, 2025 | May 23, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jul 3, 2025 | May 21, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 15, 2025 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2024 | Apr 30, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 15, 2025 | Apr 18, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 15, 2025 | Apr 15, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 11, 2025 | Apr 14, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 7, 2025 | Apr 11, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 31, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 14, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 4, 2024 | Oct 10, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 14, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 16, 2024 | Jul 16, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 16, 2024 | Jul 16, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 19, 2024 | Jun 21, 2024 | SEC EDGAR |